These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15334065)

  • 1. Tumor formation in p53 mutant ovaries transplanted into wild-type female hosts.
    Chen CM; Chang JL; Behringer RR
    Oncogene; 2004 Oct; 23(46):7722-5. PubMed ID: 15334065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulosa cell tumorigenesis in genetically hypogonadal-immunodeficient mice grafted with ovaries from tumor-susceptible donors.
    Beamer WG; Shultz KL; Tennent BJ; Shultz LD
    Cancer Res; 1993 Aug; 53(16):3741-6. PubMed ID: 8339285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced susceptibility to chemical induction of ovarian tumors in mice with a germ line p53 mutation.
    Wang Y; Zhang Z; Lu Y; Yao R; Jia D; Wen W; LaRegina M; Crist K; Lubet R; You M
    Mol Cancer Res; 2008 Jan; 6(1):99-109. PubMed ID: 18234966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 mutation is infrequent in clear cell carcinoma of the ovary.
    Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS
    Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distant metastases in ovarian cancer: association with p53 mutations.
    Sood AK; Sorosky JI; Dolan M; Anderson B; Buller RE
    Clin Cancer Res; 1999 Sep; 5(9):2485-90. PubMed ID: 10499623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation and overexpression of p53 in early-stage epithelial ovarian cancer.
    Kohler MF; Kerns BJ; Humphrey PA; Marks JR; Bast RC; Berchuck A
    Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):643-50. PubMed ID: 8469448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neu.
    Hakim AA; Barry CP; Barnes HJ; Anderson KE; Petitte J; Whitaker R; Lancaster JM; Wenham RM; Carver DK; Turbov J; Berchuck A; Kopelovich L; Rodriguez GC
    Cancer Prev Res (Phila); 2009 Feb; 2(2):114-21. PubMed ID: 19174584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [P53-status in primary ovarian carcinomas, ovarian metastases of neoplasms in other sites and benign ovarian tumors: predictive value in comparison to histopathological parameters].
    Casper F; Weikel W; Schaffrath M; Kuner RP; Hoffmann G; Pollow B; Pollow K
    Zentralbl Gynakol; 2000; 122(3):153-9. PubMed ID: 10756599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo studies of adenovirus-mediated p53 gene therapy for cis-platinum-resistant human ovarian tumor xenografts.
    Song K; Cowan KH; Sinha BK
    Oncol Res; 1999; 11(3):153-9. PubMed ID: 10527075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development.
    Jerry DJ; Kittrell FS; Kuperwasser C; Laucirica R; Dickinson ES; Bonilla PJ; Butel JS; Medina D
    Oncogene; 2000 Feb; 19(8):1052-8. PubMed ID: 10713689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium.
    Flesken-Nikitin A; Choi KC; Eng JP; Shmidt EN; Nikitin AY
    Cancer Res; 2003 Jul; 63(13):3459-63. PubMed ID: 12839925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis.
    Kiaris H; Chatzistamou I; Trimis G; Frangou-Plemmenou M; Pafiti-Kondi A; Kalofoutis A
    Cancer Res; 2005 Mar; 65(5):1627-30. PubMed ID: 15753354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
    Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
    Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosis.
    Buller RE; Sood A; Fullenkamp C; Sorosky J; Powills K; Anderson B
    Cancer Gene Ther; 1997; 4(4):239-45. PubMed ID: 9253509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes.
    Sasaki R; Narisawa-Saito M; Yugawa T; Fujita M; Tashiro H; Katabuchi H; Kiyono T
    Carcinogenesis; 2009 Mar; 30(3):423-31. PubMed ID: 19126650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
    Corney DC; Flesken-Nikitin A; Godwin AK; Wang W; Nikitin AY
    Cancer Res; 2007 Sep; 67(18):8433-8. PubMed ID: 17823410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 mutations in epithelial ovarian cancers: possible role in predicting chemoresistance.
    Laframboise S; Chapman W; McLaughlin J; Andrulis IL
    Cancer J; 2000; 6(5):302-8. PubMed ID: 11079169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA1 and p53 protein expression in cultured ovarian surface epithelial cells derived from women with and without a BRCA1 germline mutation.
    Piek JM; Dorsman JC; Massuger LF; Ansink AC; Weegenaar J; Shvarts A; Kenemans P; Verheijen RH
    Arch Gynecol Obstet; 2006 Oct; 274(6):327-31. PubMed ID: 16826413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization of cis-platinum by a recombinant adenovirus vector expressing wild-type p53 gene in human ovarian carcinomas.
    Song K; Li Z; Seth P; Cowan KH; Sinha BK
    Oncol Res; 1997; 9(11-12):603-9. PubMed ID: 9563008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunofluorometric assay of p53 protein versus sequencing of p53 exons 5 to 9 for the detection of p53 abnormalities in ovarian carcinoma.
    Lianidou ES; Levesque MA; Katsaros D; Angelopoulou K; Yu H; Genta F; Arisio R; Massobrio M; Bharaj B; Diamandis EP
    Anticancer Res; 1999; 19(1B):749-56. PubMed ID: 10216487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.